摘要
近年来,随着基础与临床研究的进展,医务工作者对肝硬化的临床诊治有了进一步的认识.同时,国内关于肝硬化的中医证候规律、中西医结合治疗的研究日趋增多,尤其是在抗肝纤维化方面中医中药发挥了重要的作用.本指南在2008版《中医内科常见病诊疗指南》的基础上进行修订,项目组按照中医药标准化、循证医学、技术指导文件的相关要求,通过文献研究、专家访谈、问卷调查、临床问题确定、证据分级、推荐意见形成、征求意见等多种形式最终形成一套可行的中医药诊疗指南以切实、规范地指导临床诊疗.该指南经中华中医药学会批准发布,标准编号:T/CACM1576-2024.
Abstract
In recent years,with the advances in basic and clinical research,medical workers have gained a deeper understanding of the clinical diagnosis and treatment of liver cirrhosis,and meanwhile,more studies have been conducted on the traditional Chinese medicine(TCM)syndromes and integrated traditional Chinese and Western medicine treatment of liver cirrhosis in China,especially in the field of anti-liver fibrosis treatment where TCM plays an important role.This guideline is revised based on the 2008 edition of Guidelines for the diagnosis and treatment of common diseases in Chinese internal medicine,and in accordance with related requirements in TCM standardization,evidence-based medicine,and technical guidance documents,the project team formed the guidelines for TCM diagnosis and treatment through literature research,expert interview,questionnaire survey,identification of clinical problems,grading of evidence,formation of recommendation opinions,and soliciting opinions,so as to provide practical and standardized guidelines for clinical diagnosis and treatment.This guideline has been approved by China Association of Chinese Medicine,with the standard number of T/CACM1576-2024.
基金项目
国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023005)
首都卫生发展科研专项(首发2024-1-2173)
国家科技期刊平台
NSTL
万方数据